Found: 7
Select item for more details and to access through your institution.
No Phenotypic Differences for Polycystic Ovary Syndrome (PCOS) Between Women With and Without Type 1 Diabetes Mellitus.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Impact of atorvastatin plus n-3 PUFA on metabolic, inflammatory and coagulative parameters in metabolic syndrome without and with type 2 diabetes mellitus.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
- Published in:
- Human Reproduction, 2013, v. 28, n. 7, p. 1919, doi. 10.1093/humrep/det105
- By:
- Publication type:
- Article
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency.
- Published in:
- Hormone Research in Paediatrics, 2014, v. 81, n. 6, p. 379, doi. 10.1159/000356907
- By:
- Publication type:
- Article
Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study.
- Published in:
- Endocrine (1355008X), 2018, v. 61, n. 1, p. 118, doi. 10.1007/s12020-018-1524-5
- By:
- Publication type:
- Article
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report.
- Published in:
- BMC Endocrine Disorders, 2018, v. 18, p. 1, doi. 10.1186/s12902-018-0231-9
- By:
- Publication type:
- Article